Endeavor BioMedicines

Endeavor BioMedicines is a clinical-stage biotechnology company dedicated to developing transformative medicines for patients with life-threatening diseases. They are focused on disrupting disease progression and potentially reversing disease trajectory with their innovative therapies. Their pipeline currently consists of two investigational candidates: ENV-101, a Hedgehog (Hh) signaling pathway inhibitor for the treatment of fibrotic lung disease, including idiopathic pulmonary fibrosis (IPF), and ENV-501, a human epidermal growth factor 3 (HER3)-targeted antibody-drug conjugate (ADC) for the treatment of HER3-positive solid tumors.

Endeavor BioMedicines is committed to pushing the boundaries of medical innovation and has assembled a highly credentialed leadership team with deep experience in drug development. Their vibrant and passionate company culture empowers individuals and teams to go beyond the “norm,” all with the shared goal of restoring hope for patients and their families. They are headquartered in San Diego, California, and are actively seeking talented individuals to join their team.

Endeavor BioMedicines is a clinical-stage biotechnology company dedicated to developing medicines that deliver transformative clinical benefits for patients with life-threatening diseases. The company’s mission is to disrupt the underlying mechanisms of intractable diseases like fibrotic lung disease and cancer, moving beyond simply slowing disease progression to potentially reversing its course and restoring hope for patients.

Endeavor BioMedicines cultivates a vibrant and passionate culture that reflects its mission to deliver innovative therapies for patients with life-threatening diseases. The company empowers its employees to go beyond the norm, fostering a supportive and inspiring environment where individuals and teams can collaborate and leverage their expertise to achieve impactful results. This collaborative and driven environment emphasizes innovation, scientific excellence, and a shared commitment to restoring hope for patients and their families.

Endeavor BioMedicines values a culture of inclusivity and diversity, believing it fosters innovation and drives progress. They are committed to creating a supportive and inspiring workplace that empowers individuals and teams to go beyond the norm, all with the shared goal of restoring hope for patients and their families. This commitment is reflected in their diverse leadership team and the company's focus on attracting and retaining a workforce that reflects the diversity of the patient populations they serve.